http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104997727-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
filingDate 2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104997727-B
titleOfInvention A kind of curcumin micella nasal-cavity administration solution and preparation method thereof
abstract The invention discloses a kind of curcumin micella nasal-cavity administration solution, it is main ingredient and preservative, isotonic regulator including curcumin, it is excipient substance characterized by further comprising Polyvinylcaprolactame polyvinyl acetate ethylene glycol copolymer, medical polyethylene glycol class auxiliary material and RGD peptide, curcumin main ingredient and Polyvinylcaprolactame polyvinyl acetate ethylene glycol copolymer excipient substance mass ratio are 1:12~1:Between 20, medical polyethylene glycol class auxiliary material and Polyvinylcaprolactame polyvinyl acetate ethylene glycol copolymer excipient substance mass ratio are 1:20~1:Between 40, RGD peptide and medical polyethylene glycol class auxiliary material mass ratio are 1:2~1:Between 4.Curcumin micella nasal-cavity administration solution prepared by the present invention, so that curcumin has good dissolving its preparation method in aqueous, not only solve the water solubility of curcumin, improve curcumin stability of molecule, while micella particle diameter is adjusted to suitable particle size range(150~220nm), improve the stability of micellar aqueous solution.
priorityDate 2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100277053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6842
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID136217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID820085
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID182225
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450281383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21333
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID819276
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID136217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415721994
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36511
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426067522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20317181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447843440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6971205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430895435
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID182225

Total number of triples: 44.